Back to companies

NGeneBio Co., Ltd.

354200KRKRX

엔젠바이오

Revenue
₩5.7bn
FY2024
Operating income
-₩16.1bn
FY2024
Employees
—
Founded
—

Source: Korea Financial Supervisory Service DART (Open DART API)